A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis

NCT01113034 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Bronchiectasis

Interventions

DRUG: DAS181 dry powder, formulation F02
DRUG: Respitose ML006 (DMV-Fonterra)

Sponsor

Ansun Biopharma, Inc.

Collaborators

[object Object]